4.2 Article

Use of health-related quality of life in prescribing research. Part 2: methodological considerations for the assessment of health-related quality of life in clinical trials

Journal

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
Volume 29, Issue 1, Pages 85-94

Publisher

BLACKWELL PUBLISHING LTD
DOI: 10.1046/j.0269-4727.2003.00520.x

Keywords

health-related quality of life; missing data; protocol; randomized controlled trial; timing

Ask authors/readers for more resources

This article aims to address key methodological issues that should be considered when assessing health-related quality of life (HRQoL) in a clinical trial. These include justification for the selection of HRQoL as a primary or secondary outcome and choice of an appropriate instrument to assess HRQoL, which meets basic psychometric properties. In addition we consider ways to minimize bias within the trial through optimization of compliance and timing of assessments.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available